加拿大的癫痫患者面临Teva-clobazam的短缺,如果他们换药,就有可能被缉获。 Epilepsy patients in Canada face shortages of Teva-clobazam, risking seizures if they switch drugs.

从5月开始,预计到2022年4月,加拿大的癫痫药物Teva-clobazam持续短缺,这使担心改用替代药物后会被缉获的病人感到关切。 An ongoing shortage of epilepsy drug Teva-clobazam in Canada, starting in May and expected until April 2022, is causing concern for patients who fear seizures if they switch to alternative medications. 加拿大卫生部报告说,短缺是由于制造业中断造成的。 Health Canada reports the shortage is due to manufacturing disruption. 根据加拿大联盟的警告, 改变药物可以引发突破性发作, 影响26万加拿大患者. The Canadian Epilepsy Alliance warns that switching medications can trigger breakthrough seizures, affecting the 260,000 Canadians with epilepsy.